1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 5:Agreement and differences of delineation between EPI- and HASTE-DWI determined pretreatmenta
Agreement in % Weighted κ (95% CI) Differences of Means Wilcoxon Signed Rank (P Value) HASTE-DWI observer 1 versus EPI-DWI observer 1 78% 0.12 (−0.01–0.28) 0.65 <.0005 HASTE-DWI observer 2 versus EPI-DWI observer 2 81% 0.07 (−0.04–0.18) 0.57 <.0005
↵a The delineation of primary tumors and lymph nodes is determined by using a 3-point scale: score 1 = poor delineation, score 2 = moderate delineation, and score 3 = good delineation.